Literature DB >> 1354447

Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype.

P T Schellekens1, M Tersmette, M T Roos, R P Keet, F de Wolf, R A Coutinho, F Miedema.   

Abstract

OBJECTIVE: To determine the kinetics of decline of CD4+ lymphocytes in HIV-1-infected asymptomatic homosexual men.
METHODS: CD4+ lymphocytes were enumerated in a cohort of 187 HIV-1-infected initially asymptomatic homosexual men seen at 3-month intervals over 5 years. During follow-up, 45 men progressed to AIDS (excluding cases presenting with Kaposi's sarcoma). Correlation between rate of CD4+ cell decline and presence of a particular HIV-1 biological phenotype was analysed in 43 participants.
RESULTS: CD4+ cell counts declined slowly and continuously in HIV-1-seropositive men who remained asymptomatic during follow-up. A biphasic CD4+ cell count decline was observed in the group who developed AIDS: the decline was slow and steady (5.6 x 10(6)/l per month, similar to that observed in the asymptomatic group) until 18 months before AIDS diagnosis, but became three to five times faster thereafter. Rapid CD4+ cell decline was significantly related to syncytium-inducing, fast-replicating HIV-1 isolates; during the period of slow and steady CD4+ cell count decline, non-syncytium-inducing isolates were predominant.
CONCLUSIONS: At an average of 18 months preceding AIDS diagnosis, a three to fivefold increase in the rate of loss of CD4+ lymphocytes occurs, and may be related to the appearance of a more virulent HIV-1 phenotype.

Entities:  

Mesh:

Year:  1992        PMID: 1354447     DOI: 10.1097/00002030-199207000-00008

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  29 in total

Review 1.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

Review 2.  Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.

Authors:  Won-Tak Choi; Yilei Yang; Yan Xu; Jing An
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

3.  A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry.

Authors:  Won-Tak Choi; Santhosh Kumar; Navid Madani; Xiaofeng Han; Shaomin Tian; Chang-Zhi Dong; Dongxiang Liu; Srinivas Duggineni; Jian Yuan; Joseph G Sodroski; Ziwei Huang; Jing An
Journal:  Biochemistry       Date:  2012-08-29       Impact factor: 3.162

4.  CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction.

Authors:  A Kinter; A Catanzaro; J Monaco; M Ruiz; J Justement; S Moir; J Arthos; A Oliva; L Ehler; S Mizell; R Jackson; M Ostrowski; J Hoxie; R Offord; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

Review 5.  Guarding against the most dangerous emerging pathogens.

Authors:  P W Ewald
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

6.  Acquisition of syncytium-inducing HIV-1 strains during therapy with zidovudine alone or combined with alpha interferon or didanosine.

Authors:  Y Torres; M Leal; C Rey; F J Medrano; A Sánchez-Quijano; E Lissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

Review 7.  Immune dysregulation and CD4+ T cell loss in HIV-1 infection.

Authors:  L Meyaard; F Miedema
Journal:  Springer Semin Immunopathol       Date:  1997

8.  Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression.

Authors:  Ryan M Troyer; Kalonji R Collins; Awet Abraha; Erika Fraundorf; Dawn M Moore; Randall W Krizan; Zahra Toossi; Robert L Colebunders; Mark A Jensen; James I Mullins; Guido Vanham; Eric J Arts
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 9.  Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases.

Authors:  Won-Tak Choi; Jing An
Journal:  Exp Biol Med (Maywood)       Date:  2011-05-12

10.  Serum 27E10 antigen: a new potential marker for staging HIV disease.

Authors:  N Lügering; R Stoll; T Kucharzik; G Burmeister; C Sorg; W Domschke
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.